Drug: calcitriol

Manufacturer: misc

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication:

• managing secondary hyperparathyroidism and resultant metabolic bone disease in patients with moderate to severe chronic renal failure (Ccr 15-55 mL/min)
• managing hypocalcemia and the resultant metabolic bone disease in patients undergoing chronic renal dialysis
• managing hypocalcemia and its clinical manifestations in patients with postsurgical hypoparathyroidism, idiopathic hypoparathyroidism, and pseudohypoparathyroidism

Disease: hypocalcemia, secondary hyperparathyroidism

Therapeutic Area: Gastroenterology, Rheumatology, Dermatology, Immunology

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: N/A